Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system.

N. Gahrmani, N. Gorban-Brennan, A. S. Kliger, F. O. Finkelstein

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Previous studies have shown the incidence of peritonitis to be generally lower for patients performing continuous cycling peritoneal dialysis (CCPD) than patients maintained on continuous ambulatory peritoneal dialysis (CAPD). Recent changes in CAPD techniques, particularly the introduction of the UltraBag system, have resulted in a marked decrease in peritonitis rates in CAPD patients. The purpose of the present study was to compare peritoneal dialysis-related infections in 73 patients treated with CCPD and 57 patients treated with CAPD using the UltraBag system for a 12-month period. Demographic data of the two groups were comparable. Peritonitis rates were significantly lower in the patients treated with CAPD on the UltraBag (one infection/23 patient-months) than in patients treated with CCPD (one infection/14.4 patient-months, p < 0.05). Exit-site infections were also significantly lower in patients treated with CAPD (one episode/35 patient-months) compared to patients treated with CCPD (one episode/11.5 patient-months, p < 0.05). The spectrum of organisms causing infection was similar in both groups of patients. The study suggests that peritonitis and exit-site infections are significantly less common in patients treated with CAPD with the UltraBag system than in patients treated with CCPD.

Original languageEnglish (US)
Pages (from-to)164-167
Number of pages4
JournalAdvances in peritoneal dialysis. Conference on Peritoneal Dialysis
Volume11
StatePublished - 1995

Fingerprint

Continuous Ambulatory Peritoneal Dialysis
Peritoneal Dialysis
Chronic Kidney Failure
Infection
Peritonitis

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{f8726d51e20b4528b2d13e651e241b0b,
title = "Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system.",
abstract = "Previous studies have shown the incidence of peritonitis to be generally lower for patients performing continuous cycling peritoneal dialysis (CCPD) than patients maintained on continuous ambulatory peritoneal dialysis (CAPD). Recent changes in CAPD techniques, particularly the introduction of the UltraBag system, have resulted in a marked decrease in peritonitis rates in CAPD patients. The purpose of the present study was to compare peritoneal dialysis-related infections in 73 patients treated with CCPD and 57 patients treated with CAPD using the UltraBag system for a 12-month period. Demographic data of the two groups were comparable. Peritonitis rates were significantly lower in the patients treated with CAPD on the UltraBag (one infection/23 patient-months) than in patients treated with CCPD (one infection/14.4 patient-months, p < 0.05). Exit-site infections were also significantly lower in patients treated with CAPD (one episode/35 patient-months) compared to patients treated with CCPD (one episode/11.5 patient-months, p < 0.05). The spectrum of organisms causing infection was similar in both groups of patients. The study suggests that peritonitis and exit-site infections are significantly less common in patients treated with CAPD with the UltraBag system than in patients treated with CCPD.",
author = "N. Gahrmani and N. Gorban-Brennan and Kliger, {A. S.} and Finkelstein, {F. O.}",
year = "1995",
language = "English (US)",
volume = "11",
pages = "164--167",
journal = "Advances in peritoneal dialysis. Conference on Peritoneal Dialysis",
issn = "1197-8554",
publisher = "Peritoneal Dialysis Bulletin",

}

Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system. / Gahrmani, N.; Gorban-Brennan, N.; Kliger, A. S.; Finkelstein, F. O.

In: Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 11, 1995, p. 164-167.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system.

AU - Gahrmani, N.

AU - Gorban-Brennan, N.

AU - Kliger, A. S.

AU - Finkelstein, F. O.

PY - 1995

Y1 - 1995

N2 - Previous studies have shown the incidence of peritonitis to be generally lower for patients performing continuous cycling peritoneal dialysis (CCPD) than patients maintained on continuous ambulatory peritoneal dialysis (CAPD). Recent changes in CAPD techniques, particularly the introduction of the UltraBag system, have resulted in a marked decrease in peritonitis rates in CAPD patients. The purpose of the present study was to compare peritoneal dialysis-related infections in 73 patients treated with CCPD and 57 patients treated with CAPD using the UltraBag system for a 12-month period. Demographic data of the two groups were comparable. Peritonitis rates were significantly lower in the patients treated with CAPD on the UltraBag (one infection/23 patient-months) than in patients treated with CCPD (one infection/14.4 patient-months, p < 0.05). Exit-site infections were also significantly lower in patients treated with CAPD (one episode/35 patient-months) compared to patients treated with CCPD (one episode/11.5 patient-months, p < 0.05). The spectrum of organisms causing infection was similar in both groups of patients. The study suggests that peritonitis and exit-site infections are significantly less common in patients treated with CAPD with the UltraBag system than in patients treated with CCPD.

AB - Previous studies have shown the incidence of peritonitis to be generally lower for patients performing continuous cycling peritoneal dialysis (CCPD) than patients maintained on continuous ambulatory peritoneal dialysis (CAPD). Recent changes in CAPD techniques, particularly the introduction of the UltraBag system, have resulted in a marked decrease in peritonitis rates in CAPD patients. The purpose of the present study was to compare peritoneal dialysis-related infections in 73 patients treated with CCPD and 57 patients treated with CAPD using the UltraBag system for a 12-month period. Demographic data of the two groups were comparable. Peritonitis rates were significantly lower in the patients treated with CAPD on the UltraBag (one infection/23 patient-months) than in patients treated with CCPD (one infection/14.4 patient-months, p < 0.05). Exit-site infections were also significantly lower in patients treated with CAPD (one episode/35 patient-months) compared to patients treated with CCPD (one episode/11.5 patient-months, p < 0.05). The spectrum of organisms causing infection was similar in both groups of patients. The study suggests that peritonitis and exit-site infections are significantly less common in patients treated with CAPD with the UltraBag system than in patients treated with CCPD.

UR - http://www.scopus.com/inward/record.url?scp=0029449991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029449991&partnerID=8YFLogxK

M3 - Article

C2 - 8534695

AN - SCOPUS:0029449991

VL - 11

SP - 164

EP - 167

JO - Advances in peritoneal dialysis. Conference on Peritoneal Dialysis

JF - Advances in peritoneal dialysis. Conference on Peritoneal Dialysis

SN - 1197-8554

ER -